Exhibit 31.1


                                  CERTIFICATION

         Pursuant to the requirements of Rules 13a-14 of the Securities Exchange
Act of 1934, as amended, James R. Musick provides the following certification.

         I, James R. Musick, President, Chief Executive Officer, Chairman of the
Board of Directors and Principal Financial Officer of Vitro Diagnostics, Inc.
("Company") certify that:

     1.   I have reviewed this quarterly report on Form 10-QSB of the Company;

     2.   Based on my knowledge, this quarterly report does not contain any
          untrue statement of a material fact or omit to state a material fact
          necessary to make the statements made, in light of the circumstances
          under which such statements were made, not misleading with respect to
          the period covered by this quarterly report;

     3.   Based on my knowledge, the financial statements, and other financial
          information included in the quarterly report, fairly present in all
          material respects the financial condition, results of operations and
          cash flows of the Company as of, and for, the periods presented in
          this quarterly report;

     4.   I am responsible for establishing and maintaining disclosure controls
          and procedures (as defined in Exchange Act Rules 13a-14 and 15-d-14)
          for the registrant and have designed such disclosure controls and
          procedures to ensure that material information relating to the Company
          is made know to me by others, particularly during the period in which
          this quarterly report is being prepared;

     5.   I have disclosed, based on my most recent evaluation, to the Company's
          auditors and the audit committee of our board of directors (or persons
          performing the equivalent functions):

          a.   All significant deficiencies in the design or operation of
               internal controls which could adversely affect the Company's
               ability to record, process, summarize and report financial date
               and have identified for the Company's auditors any material
               weaknesses in internal controls, and

          b.   Any fraud, whether or not material, that involves management or
               other employees which have a significant role in the Company's
               internal controls; and

     6.   I have indicated in this quarterly report whether or not there were
          significant changes in internal control or in other factors that could
          significantly affect internal controls subsequent to the date of my
          most recent evaluation, including any corrective actions with regard
          to significant deficiencies and material weaknesses.

Date: September 16, 2008


                                         By: /s/ James R. Musick
                                             -----------------------------------
                                             James R. Musick, President, Chief
                                             Executive Officer, Chairman
                                             of the Board of Directors, and
                                             Principal Financial Officer